(Q40507932)
Statements
Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab (English)
Ali R Jazirehi
Devasis Chatterjee
Lee Goodglick
Benjamin Bonavida
1 reference